endothelial dysfunction

Showing 1 posts of 1 posts found.

Vicore announces initiation of proof-of-concept study for endothelial dysfunction treatments

May 4, 2023
Research and Development Cardiology, Vicore Pharma, clinical trials, endothelial dysfunction, organ damage

Vicore Pharma Holding AB has announced that it has dosed the first patient with C21 in its randomised, double-blind, placebo-controlled, …

Latest content